Skip to content
  • Thu. Mar 23rd, 2023

DELAWARE TECHNOLOGY PARK

Innovation Begins Here

  • About Us
    • About Us
    • History
    • Leadership
    • Strategic Partners and Resources
    • Current Partners
  • DTP Advantage
  • DTP@STAR Incubator
  • Resident Innovators
    • Current Residents
  • News
  • Contact Us
News

Prelude Therapeutics Gets $50M Series C Funding

Bydtpadmin1

Sep 3, 2020

Click here to the the full Delaware Business Times article.

Post navigation

Booz Allen Foundation COVID-19 $1M Innovation Fund Now Open For Applications!
As Delaware’s Bioscience Sector Grows, Space Is In Short Supply

By dtpadmin1

DELAWARE TECHNOLOGY PARK

Innovation Begins Here

Proudly powered by WordPress | Theme: Newspaperex by Themeansar.

  • Home
  • About Us
  • Calendar
  • Contact Us
  • Current Partners
  • DTP Advantage
  • DTP@STAR Incubator
  • Event Calendar
  • History
  • Leadership
  • News
  • Resident Innovators
  • Resources
  • Strategic Partners and Resources
  • Support Our Innovators